0 followers
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Their lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked... Read more
Scott Byrd
Tessera Therapeutics
2 followers
Pyxis Oncology
1 follower
Mineralys Therapeutics
1 follower
Vial
5 followers
Thermo Fisher Scientific
155 followers
Biogen
114 followers
Alexion Pharmaceuticals
34 followers
Catalent
17 followers
Cytiva
10 followers
Formation Bio
2 followers
Apellis Pharmaceuticals
7 followers
Explore companies